Stoke Therapeutics STOK
NASDAQ STOK
$26.01 +0.01 (+0.04%)
At close: Oct 1, 2026 · 4:00 PM EDT

Stoke Therapeutics (STOK) Non Operating Income (2019 - 2026)

Updated

Stoke Therapeutics' Non Operating Income was $3.81 million in Q2 2026, down 0.2% from $3.82 million a year earlier but up 11.6% from the prior quarter.

Analysis

Stoke Therapeutics (STOK) Non Operating Income (2019 - 2026) Analysis & Trends

On a trailing twelve-month basis, Stoke Therapeutics' Non Operating Income was $14.2 million through Jun 30, 2026, up 5.3% year-over-year; for FY2025, it was $13.71 million, up 10.6% from FY2024.

  • Non Operating Income has now increased for three consecutive years, with a five-year compound annual growth rate of 76.5% (FY2020 to FY2025).
  • In earlier years, Non Operating Income was $12.39 million in FY2024 (+23.0%), $10.07 million in FY2023 (+206.3%), $3.29 million in FY2022 and $260,000 in FY2021 (-67.5%).
  • Quarterly Non Operating Income has moved between $78,000 (Q4 2021) and $3.82 million (Q2 2025) over five years.
  • Compared with a year earlier, Non Operating Income was higher in six of the last eight quarters, with growth averaging 16.1%.
  • The best year-over-year quarter for Non Operating Income over five years was Q2 2022 (growth of 845.2%); the worst was Q1 2024 (a decline of 6.9%).
  • Per Business Quant data, STOK's Non Operating Income in the three quarters before Q2 2026 was $3.42 million (Q1 2026), $3.51 million (Q4 2025) and $3.47 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Op. Inc. (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -73.00 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 387.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Stoke Therapeutics 1.62 Bn 453.12 Mn - 3.81 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 3.81 Mn
Mar 31, 2026 3.42 Mn
Dec 31, 2025 3.51 Mn
Sep 30, 2025 3.47 Mn
Jun 30, 2025 3.82 Mn
Mar 31, 2025 2.92 Mn
Dec 31, 2024 3.17 Mn
Sep 30, 2024 3.57 Mn
Jun 30, 2024 3.65 Mn
Mar 31, 2024 2.00 Mn
Dec 31, 2023 2.63 Mn
Sep 30, 2023 2.69 Mn
Jun 30, 2023 2.61 Mn
Mar 31, 2023 2.15 Mn
Dec 31, 2022 1.52 Mn
Sep 30, 2022 1.04 Mn
Jun 30, 2022 586,000.00
Mar 31, 2022 146,000.00
Dec 31, 2021 78,000.00
Sep 30, 2021 86,000.00
API Access

Stoke Therapeutics Non Operating Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-income&ticker=STOK&period=max&api_key=YOUR_API_KEY